Molecular Characterization of Antibiotic Resistance Associated with TEM and CTX-M ESBL in Uropathogenic E. coli Strains Isolated from Outpatients
Publish place: IRANIAN JOURNAL of PATHOLOGY، Vol: 16، Issue: 4
Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 187
This Paper With 6 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJP-16-4_006
تاریخ نمایه سازی: 14 بهمن 1400
Abstract:
Background & Objective: Escherichia coli (E. coli) is a leading cause of urinary tract infections becoming resistant against beta-lactams and cephalosporins through different mechanisms, including ESBL production due to the presence of ESBL specific genes, including blaCTX-M and blaTEM. The purpose of the present study was to detect the uropathogenic E. coli strains producing the ESBL.Methods: A total of ۱۰۰ isolates of uropathogenic E. coli were randomly selected in a period of ۶ months and their resistances to a number of antibiotics including amoxicillin, amikacin, gentamicin, ciprofloxacin, ceftazidime, cefotaxime, ceftriaxone, ceftizoxime, nalidixic acid, and nitrofurantoin were determined. Then, DDT test was used to detect the presence of ESBL. Finally, the presence of blaCTX-M and blaTEM resistance genes was analyzed by PCR method.Results: The resistance profile of bacterial isolates to the antibiotics was as follows: amoxicillin: ۱۶.۷%, amikacin: ۷.۸%, gentamicin: ۲۰.۳%, ciprofloxacin: ۳۵.۵/%, ceftazidime: ۳۵.۰%, cefotaxime: ۴۰.۰%, ceftriaxone: ۴۱.۳%, nalidixic acid: ۶۴.۰%, nitrofurantoin: ۹.۷%, and ceftizoxime: ۱۰۰%. Of these, ۲۸ isolates (۲۸%) were reported to be resistant to cefotaxime, ceftazidime, and ceftriaxone. In DDT test, ۲۱ ESBL positive cases (۲۱%) were detected. PCR results showed that the presence of blaCTX-M and blaTEM genes in the isolates were ۲۱% and ۲۰%, respectively. Conclusion: Regarding the production of ESBL by some E. coli isolates, phenotypic detection of ESBL-producing isolates is routinely suggested in the laboratories. Likewise, the treatment regimen should be selected regarding the ESBL production to avoid treatment failure.
Keywords:
Authors
- -
Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.
- -
Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
- -
Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.
- -
Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :